Johnson & Johnson (NYSE: JNJ) reported fourth quarter 2023 earnings results today. Reported sales increased 7.3% year-over-year to $21.4 billion. Net earnings increased 28% to $4.1 billion and EPS rose 39.3% to $1.70 from last year. Adjusted EPS rose 11.7% to $2.29. Both revenue and earnings beat estimates. For the full year of 2024, the […]
“Johnson & Johnson (NYSE: JNJ) reported fourth quarter 2023 earnings results today. Reported sales increased 7.3% year-over-year to $21.4 billion. Net earnings increased 28% to $4.1 billion and EPS rose 39.3% to $1.70 from last year. Adjusted EPS rose 11.7% to $2.29. Both revenue and earnings beat estimates. For the full year of 2024, the […]
· January 23, 2024
Johnson & Johnson (NYSE: JNJ) reported fourth quarter 2023 earnings results today.
Reported sales increased 7.3% year-over-year to $21.4 billion.
Net earnings increased 28% to $4.1 billion and EPS rose 39.3% to $1.70 from last year. Adjusted EPS rose 11.7% to $2.29.
Both revenue and earnings beat estimates.
For the full year of 2024, the company expects adjusted EPS of $10.55-10.75. Reported sales are expected to be $87.8-88.6 billion.
The stock stayed red during premarket hours on Tuesday.
